156 related articles for article (PubMed ID: 29046638)
1. Blockade of Cannabinoid CB1 Receptors in the Dorsal Periaqueductal Gray Unmasks the Antinociceptive Effect of Local Injections of Anandamide in Mice.
Mascarenhas DC; Gomes KS; Sorregotti T; Nunes-de-Souza RL
Front Pharmacol; 2017; 8():695. PubMed ID: 29046638
[TBL] [Abstract][Full Text] [Related]
2. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
3. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
Godoi MM; Junior HZ; da Cunha JM; Zanoveli JM
Pharmacol Biochem Behav; 2020 Jul; 194():172938. PubMed ID: 32376258
[TBL] [Abstract][Full Text] [Related]
4. Anandamide in the dorsal periaqueductal gray inhibits sensory input without a correlation to sympathoexcitation.
Roberts CJ; Hopp FA; Hogan QH; Dean C
Neurobiol Pain; 2022; 12():100104. PubMed ID: 36531614
[TBL] [Abstract][Full Text] [Related]
5. Role of TRPV1 channels of the dorsal periaqueductal gray in the modulation of nociception and open elevated plus maze-induced antinociception in mice.
Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
Behav Brain Res; 2015 Oct; 292():547-54. PubMed ID: 26183651
[TBL] [Abstract][Full Text] [Related]
6. CB
Medeiros P; Oliveira-Silva M; Negrini-Ferrari SE; Medeiros AC; Elias-Filho DH; Coimbra NC; de Freitas RL
Brain Res Bull; 2020 Dec; 165():118-128. PubMed ID: 33038420
[TBL] [Abstract][Full Text] [Related]
7. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
Mol Pain; 2016; 12():. PubMed ID: 27178246
[TBL] [Abstract][Full Text] [Related]
8. The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors.
Batista PA; Fogaça MV; Guimarães FS
Behav Brain Res; 2015 Oct; 293():182-8. PubMed ID: 26187694
[TBL] [Abstract][Full Text] [Related]
9. Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.
Casarotto PC; Terzian AL; Aguiar DC; Zangrossi H; Guimarães FS; Wotjak CT; Moreira FA
Neuropsychopharmacology; 2012 Jan; 37(2):478-86. PubMed ID: 21937980
[TBL] [Abstract][Full Text] [Related]
10. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
[TBL] [Abstract][Full Text] [Related]
11. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.
Lisboa SF; Guimarães FS
Neuropharmacology; 2012 Jun; 62(8):2455-62. PubMed ID: 22394688
[TBL] [Abstract][Full Text] [Related]
12. Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro.
Kim SR; Lee DY; Chung ES; Oh UT; Kim SU; Jin BK
J Neurosci; 2005 Jan; 25(3):662-71. PubMed ID: 15659603
[TBL] [Abstract][Full Text] [Related]
13. Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms.
Starowicz K; Makuch W; Osikowicz M; Piscitelli F; Petrosino S; Di Marzo V; Przewlocka B
Neuropharmacology; 2012 Mar; 62(4):1746-55. PubMed ID: 22178705
[TBL] [Abstract][Full Text] [Related]
14. Dual mechanism of TRKB activation by anandamide through CB1 and TRPV1 receptors.
Diniz CRAF; Biojone C; Joca SRL; Rantamäki T; Castrén E; Guimarães FS; Casarotto PC
PeerJ; 2019; 7():e6493. PubMed ID: 30809460
[TBL] [Abstract][Full Text] [Related]
15. Functional interaction between orexin-1 and CB1 receptors in the periaqueductal gray matter during antinociception induced by chemical stimulation of the lateral hypothalamus in rats.
Esmaeili MH; Reisi Z; Ezzatpanah S; Haghparast A
Eur J Pain; 2016 Nov; 20(10):1753-1762. PubMed ID: 27301294
[TBL] [Abstract][Full Text] [Related]
16. Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning.
Uliana DL; Hott SC; Lisboa SF; Resstel LB
Neuropharmacology; 2016 Apr; 103():257-69. PubMed ID: 26724373
[TBL] [Abstract][Full Text] [Related]
17. CB
Zheng T; Zhang R; Zhang T; Zhang MN; Xu B; Song JJ; Li N; Tang HH; Wang P; Wang R; Fang Q
Brain Res; 2018 Feb; 1680():155-164. PubMed ID: 29274880
[TBL] [Abstract][Full Text] [Related]
18. CB
Dos Anjos-Garcia T; Ullah F; Falconi-Sobrinho LL; Coimbra NC
Neuropharmacology; 2017 Feb; 113(Pt A):156-166. PubMed ID: 27062913
[TBL] [Abstract][Full Text] [Related]
19. Anandamide induces matrix metalloproteinase-2 production through cannabinoid-1 receptor and transient receptor potential vanilloid-1 in human dental pulp cells in culture.
Miyashita K; Oyama T; Sakuta T; Tokuda M; Torii M
J Endod; 2012 Jun; 38(6):786-90. PubMed ID: 22595113
[TBL] [Abstract][Full Text] [Related]
20. Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats.
Schreiber AK; Neufeld M; Jesus CH; Cunha JM
Neuropharmacology; 2012 Dec; 63(8):1286-97. PubMed ID: 22959964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
